AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Daewon Pharmaceutical Co., Ltd.

₩8000 -$4000.00 (-33.33%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩8020
Day Range
₩7950₩8090
Year Range
₩7060₩13670
Market Cap
171.47B
AVG Volume
109.73K
Trailing/Forward PE
65.26/9.71
PEG ratio
1.03
Dividend Yield
3.12%
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
0200B400B600B800B2016201720182019202020212022202320242025
003220.KS Revenue (KRW) by year
PeriodRevenue (KRW)
2025605.64B
2024598.16B
2023526.95B
2022478.88B
2021354.18B
2020308.5B
2019317.83B
2018286.65B
2017265.46B
2016240.72B
Net Income (KRW)
-10B010B20B30B40B2016201720182019202020212022202320242025
003220.KS Net Income (KRW) by year
PeriodNet Income (KRW)
2025-1.38B
202414.21B
202323.92B
202231.94B
20216.99B
202017.64B
201927.29B
201823.74B
201710.74B
201620.29B
Operating Income (KRW)
020B40B60B2016201720182019202020212022202320242025
003220.KS Operating Income (KRW) by year
PeriodOperating Income (KRW)
20253.5B
202428.6B
202332.23B
202243.01B
202119.43B
202024.1B
201935.11B
201830.75B
201725.29B
201629.15B
EBITDA (KRW)
020B40B60B80B2016201720182019202020212022202320242025
003220.KS EBITDA (KRW) by year
PeriodEBITDA (KRW)
202527.23B
202444.65B
202348.47B
202261.41B
202138.59B
202040.3B
201946.88B
201840.99B
201733.9B
201636.43B
Cash Flows (KRW)
-20B020B40B2016201720182019202020212022202320242025
003220.KS Cash Flows (KRW) by year
PeriodCash Flows (KRW)
202510.91B
20249.01B
202329B
202219.96B
202110.71B
20209.17B
2019-5.68B
2018-2.55B
2017-13.46B
2016219.05M
EPS (KRW)
-5000500100015002016201720182019202020212022202320242025
003220.KS EPS (KRW) by year
PeriodEPS (KRW)
2025-65.76
2024665.11
20231110.7
20221490.45
2021322.59
2020805.48
20191252
20181086.53
2017475.61
2016914.77
Expenses (KRW)
0100B200B300BR&DSG&ACapex2016201720182019202020212022202320242025
003220.KS Expenses (KRW) by year
PeriodExpenses (KRW)
2025212.51B
2024247.75B
2023143.58B
2022132.45B
2021106.05B
202094.72B
2019115.29B
2018116.38B
201786.64B
201673.24B
Cash & Debt (KRW)
050B100B150B200BCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
003220.KS Cash & Debt (KRW) by year
PeriodCash & Debt (KRW)
202576.48B
202446.11B
202330.03B
202247.01B
202154.82B
202010.52B
201918.8B
201816.78B
20179.15B
201619.11B
Debt ratios
00.20.40.60.820182019202020212022202320242025
003220.KS Debt ratios by year
PeriodDebt ratios
20250.61
20240.73
20230.61
20220.37
20210.41
20200.26
20190.2
20180.08
Margins
0%20%40%60%2016201720182019202020212022202320242025
003220.KS Margins by year
PeriodMargins
202544.78%
202447.79%
202348.6%
202249.69%
202149.82%
202053.79%
201956.68%
201857.73%
201757.28%
201657.13%
Return on Capital
-5%0%5%10%15%2016201720182019202020212022202320242025
003220.KS Return on Capital by year
PeriodReturn on Capital
2025-0.5%
20244.99%
20239.05%
202212.84%
20213.2%
20208.29%
201913.36%
201812.96%
20176.39%
201612.53%
Shares Outstanding
010M20M30M2016201720182019202020212022202320242025
003220.KS Shares Outstanding by year
PeriodShares Outstanding
202521.45M
202421.43M
202321.2M
202220.97M
202121.22M
202020.94M
201920.94M
201820.94M
201720.95M
201620.5M
Dividends (KRW)
01002003004002016201720182019202020212022202320242025
003220.KS Dividends (KRW) by year
PeriodDividends (KRW)
2025250
2024300
2023300
2022350
2021194.17
2020147.94
2019233.4
2018226.61
2017215.82
2016209.53
Book Value Per Share (KRW)
0500010000150002016201720182019202020212022202320242025
003220.KS Book Value Per Share (KRW) by year
PeriodBook Value Per Share (KRW)
202512982.69
202413277.57
202312467.63
202211862.61
202110293.1
202010161.12
20199751.34
20188746.71
20178026.52
20167903.66
Total Assets (KRW)
0200B400B600B800B2016201720182019202020212022202320242025
003220.KS Total Assets (KRW) by year
PeriodTotal Assets (KRW)
2025613.65B
2024583.39B
2023508B
2022453.55B
2021429.58B
2020335.21B
2019327.53B
2018275.44B
2017227.2B
2016214.68B
PE Ratio
10203040med 20.12Apr 24Jul 24Nov 24Feb 25May 25Sep 25Dec 25
003220.KS PE Ratio by year
PeriodPE Ratio
Dec 2532.05
Dec 2532.21
Dec 2532.63
Dec 2532.97
Nov 2533.24
Nov 2533.21
Nov 2535.37
Nov 2534.05
Oct 2534.21
Oct 2534.29
Oct 2534.52
Oct 2534.21
Oct 2534.42
Sep 2527.1
Sep 2527.67
Sep 2527.23
Sep 2526.96
Aug 2527.27
Aug 2527.12
Aug 2527.71
Aug 2527.27
Aug 2527.06
Jul 2527.56
Jul 2528
Jul 2527.83
Jul 2527.69
Jun 2519.97
Jun 2520.23
Jun 2520.65
Jun 2520.72
May 2521
May 2520.53
May 2520.23
May 2520.65
May 2520.92
Apr 2520.75
Apr 2520.17
Apr 2519.97
Apr 2520.21
Mar 2518.3
Mar 2518.61
Mar 2518.78
Mar 2518.7
Feb 2518.72
Feb 2519.26
Feb 2518.89
Feb 2519.12
Jan 2519.48
Jan 2519.09
Jan 2519.34
Jan 2520.13
Jan 2520.1
Dec 2420.19
Dec 2420.1
Dec 2420.61
Dec 2420.28
Nov 2420.87
Nov 2421.05
Nov 2420.46
Nov 2420.74
Nov 2420.64
Oct 2420.71
Oct 2422.27
Oct 2421.17
Oct 2420.9
Sep 2413.29
Sep 2413.3
Sep 2413.15
Sep 2412.7
Aug 2413.63
Aug 2413.76
Aug 2414.68
Aug 2414.95
Aug 2414.17
Jul 2414.42
Jul 2414.6
Jul 2413.82
Jul 2412.93
Jun 2412.49
Jun 2412.66
Jun 2412.88
Jun 2413.05
May 2412.88
May 2413.07
May 2413.32
May 2412.98
May 2413.25
Apr 2413.23
Apr 2413.42
Apr 2412.58
Apr 2412.86
Mar 2411.96
Mar 2412.29
Mar 2412.16
Mar 2412.03
Feb 2411.91
Feb 2411.84
Feb 2412.06
Feb 2411.97
Feb 2411.83
Free Cash Flow Yield
-5%0%5%10%med 4.56%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
003220.KS Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 265.38%
Sep 265.41%
Sep 265.34%
Aug 265.47%
Aug 265.59%
Aug 265.42%
Aug 265.29%
Jul 265.84%
Jul 265.62%
Jul 265.42%
Jul 265.39%
Jul 265.36%
Jun 266.97%
Jun 265.96%
Jun 265.51%
Jun 264.53%
May 265.83%
May 265.34%
May 265.17%
May 265%
Apr 264.75%
Apr 264.66%
Apr 264.6%
Apr 264.94%
Apr 264.96%
Mar 269.7%
Mar 269.8%
Mar 269.69%
Mar 269.54%
Feb 268.93%
Feb 268.61%
Feb 268.71%
Feb 268.96%
Jan 268.82%
Jan 268.82%
Jan 269.01%
Jan 269.02%
Jan 268.51%
Dec 259.5%
Dec 259.46%
Dec 259.34%
Dec 259.24%
Nov 259.17%
Nov 259.17%
Nov 258.61%
Nov 258.95%
Oct 258.91%
Oct 258.88%
Oct 258.82%
Oct 258.91%
Oct 258.85%
Sep 25-2.06%
Sep 25-2.02%
Sep 25-2.05%
Sep 25-2.07%
Aug 25-2.05%
Aug 25-2.06%
Aug 25-2.02%
Aug 25-2.05%
Aug 25-2.06%
Jul 25-2.03%
Jul 25-2%
Jul 25-2.01%
Jul 25-2.02%
Jun 253.17%
Jun 253.13%
Jun 253.07%
Jun 253.06%
May 253.02%
May 253.09%
May 253.13%
May 253.07%
May 253.03%
Apr 253.05%
Apr 253.14%
Apr 253.17%
Apr 253.14%
Mar 252.07%
Mar 252.04%
Mar 252.02%
Mar 252.03%
Feb 252.03%
Feb 251.97%
Feb 252.01%
Feb 251.98%
Jan 251.95%
Jan 251.99%
Jan 251.96%
Jan 251.88%
Jan 251.89%
Dec 241.01%
Dec 241.01%
Dec 240.99%
Dec 241.01%
Nov 240.98%
Nov 240.97%
Nov 241%
Nov 240.98%
Nov 240.99%
Oct 240.98%
Price to Sales
0.20.30.40.50.6med 0.47Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
003220.KS Price to Sales by year
PeriodPrice to Sales
Sep 260.28
Sep 260.28
Sep 260.29
Aug 260.28
Aug 260.27
Aug 260.28
Aug 260.29
Jul 260.26
Jul 260.27
Jul 260.28
Jul 260.28
Jul 260.28
Jun 260.26
Jun 260.3
Jun 260.33
Jun 260.4
May 260.31
May 260.34
May 260.35
May 260.36
Apr 260.38
Apr 260.39
Apr 260.39
Apr 260.36
Apr 260.36
Mar 260.38
Mar 260.38
Mar 260.38
Mar 260.39
Feb 260.41
Feb 260.43
Feb 260.43
Feb 260.41
Jan 260.42
Jan 260.42
Jan 260.41
Jan 260.41
Jan 260.44
Dec 250.43
Dec 250.44
Dec 250.44
Dec 250.45
Nov 250.45
Nov 250.45
Nov 250.48
Nov 250.46
Oct 250.46
Oct 250.46
Oct 250.47
Oct 250.46
Oct 250.47
Sep 250.47
Sep 250.48
Sep 250.47
Sep 250.47
Aug 250.47
Aug 250.47
Aug 250.48
Aug 250.47
Aug 250.47
Jul 250.48
Jul 250.49
Jul 250.48
Jul 250.48
Jun 250.47
Jun 250.48
Jun 250.49
Jun 250.49
May 250.5
May 250.49
May 250.48
May 250.49
May 250.5
Apr 250.49
Apr 250.48
Apr 250.47
Apr 250.48
Mar 250.49
Mar 250.5
Mar 250.51
Mar 250.5
Feb 250.5
Feb 250.52
Feb 250.51
Feb 250.52
Jan 250.53
Jan 250.51
Jan 250.52
Jan 250.54
Jan 250.54
Dec 240.52
Dec 240.52
Dec 240.53
Dec 240.53
Nov 240.54
Nov 240.55
Nov 240.53
Nov 240.54
Nov 240.54
Oct 240.54
EV/EBITDA
2.557.51012.515med 8.71Oct 24Jan 25May 25Aug 25Nov 25Mar 26Jun 26
003220.KS EV/EBITDA by year
PeriodEV/EBITDA
Jun 269.81
Jun 2610.79
Jun 2611.34
Jun 2612.92
May 2610.94
May 2611.56
May 2611.81
May 2612.08
Apr 2612.51
Apr 2612.67
Apr 2612.77
Apr 2612.18
Apr 2612.14
Mar 264.29
Mar 264.27
Mar 264.29
Mar 264.33
Feb 264.52
Feb 264.62
Feb 264.59
Feb 264.51
Jan 264.55
Jan 264.55
Jan 264.49
Jan 264.49
Jan 264.66
Dec 253.73
Dec 253.75
Dec 253.78
Dec 253.8
Nov 253.82
Nov 253.82
Nov 253.99
Nov 253.89
Oct 253.9
Oct 253.9
Oct 253.92
Oct 253.9
Oct 253.91
Sep 253.81
Sep 253.86
Sep 253.82
Sep 253.79
Aug 253.82
Aug 253.81
Aug 253.87
Aug 253.82
Aug 253.8
Jul 253.85
Jul 253.89
Jul 253.88
Jul 253.86
Jun 259.52
Jun 259.6
Jun 259.73
Jun 259.76
May 259.84
May 259.69
May 259.6
May 259.73
May 259.82
Apr 259.77
Apr 259.58
Apr 259.52
Apr 259.59
Mar 258.59
Mar 258.69
Mar 258.75
Mar 258.72
Feb 258.73
Feb 258.91
Feb 258.78
Feb 258.86
Jan 258.98
Jan 258.85
Jan 258.94
Jan 259.2
Jan 259.19
Dec 249.98
Dec 249.95
Dec 2410.13
Dec 2410.01
Nov 2410.22
Nov 2410.28
Nov 2410.08
Nov 2410.17
Nov 2410.14
Oct 2410.16
Oct 2410.7
Oct 2410.32
Oct 2410.23
Sep 247.88
Sep 247.89
Sep 247.82
Sep 247.62
Aug 248.03
Aug 248.09
Aug 248.5
Aug 248.62
Aug 248.27
Price/Operating Cashflow
24681012med 6.37Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
003220.KS Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 267.19
Sep 267.14
Sep 267.23
Aug 267.06
Aug 266.91
Aug 267.13
Aug 267.31
Jul 266.62
Jul 266.87
Jul 267.13
Jul 267.17
Jul 267.21
Jun 266.37
Jun 267.45
Jun 268.06
Jun 269.8
May 267.61
May 268.3
May 268.58
May 268.88
Apr 269.35
Apr 269.53
Apr 269.65
Apr 268.98
Apr 268.95
Mar 265.26
Mar 265.21
Mar 265.27
Mar 265.35
Feb 265.72
Feb 265.94
Feb 265.87
Feb 265.7
Jan 265.79
Jan 265.79
Jan 265.67
Jan 265.67
Jan 266.01
Dec 253.27
Dec 253.28
Dec 253.33
Dec 253.36
Nov 253.39
Nov 253.39
Nov 253.61
Nov 253.47
Oct 253.49
Oct 253.5
Oct 253.52
Oct 253.49
Oct 253.51
Sep 256.38
Sep 256.51
Sep 256.41
Sep 256.34
Aug 256.42
Aug 256.38
Aug 256.52
Aug 256.42
Aug 256.37
Jul 256.48
Jul 256.59
Jul 256.55
Jul 256.51
Jun 255
Jun 255.07
Jun 255.17
Jun 255.19
May 255.26
May 255.14
May 255.07
May 255.17
May 255.24
Apr 255.2
Apr 255.05
Apr 255
Apr 255.06
Mar 256.03
Mar 256.13
Mar 256.19
Mar 256.16
Feb 256.17
Feb 256.35
Feb 256.23
Feb 256.3
Jan 256.42
Jan 256.29
Jan 256.38
Jan 256.63
Jan 256.63
Dec 2410.18
Dec 2410.14
Dec 2410.39
Dec 2410.23
Nov 2410.53
Nov 2410.62
Nov 2410.32
Nov 2410.46
Nov 2410.41
Oct 2410.45
Price to Book
0.40.60.811.2med 1Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
003220.KS Price to Book by year
PeriodPrice to Book
Sep 260.63
Sep 260.62
Sep 260.63
Aug 260.61
Aug 260.6
Aug 260.62
Aug 260.64
Jul 260.58
Jul 260.6
Jul 260.62
Jul 260.62
Jul 260.63
Jun 260.56
Jun 260.66
Jun 260.71
Jun 260.87
May 260.67
May 260.73
May 260.76
May 260.78
Apr 260.83
Apr 260.84
Apr 260.85
Apr 260.79
Apr 260.79
Mar 260.86
Mar 260.85
Mar 260.86
Mar 260.87
Feb 260.93
Feb 260.96
Feb 260.95
Feb 260.93
Jan 260.94
Jan 260.94
Jan 260.92
Jan 260.92
Jan 260.98
Dec 250.93
Dec 250.94
Dec 250.95
Dec 250.96
Nov 250.97
Nov 250.97
Nov 251.03
Nov 250.99
Oct 251
Oct 251
Oct 251.01
Oct 251
Oct 251
Sep 251
Sep 251.02
Sep 251
Sep 250.99
Aug 251
Aug 251
Aug 251.02
Aug 251
Aug 250.99
Jul 251.01
Jul 251.03
Jul 251.02
Jul 251.02
Jun 251
Jun 251.01
Jun 251.03
Jun 251.03
May 251.05
May 251.03
May 251.01
May 251.03
May 251.04
Apr 251.04
Apr 251.01
Apr 251
Apr 251.01
Mar 251.01
Mar 251.03
Mar 251.04
Mar 251.03
Feb 251.03
Feb 251.07
Feb 251.04
Feb 251.06
Jan 251.08
Jan 251.06
Jan 251.07
Jan 251.11
Jan 251.11
Dec 241.06
Dec 241.05
Dec 241.08
Dec 241.06
Nov 241.09
Nov 241.1
Nov 241.07
Nov 241.09
Nov 241.08
Oct 241.09
Daewon Pharmaceutical Co., Ltd.
003220.KS
Stockpicker

Video analysis: 003220.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.